Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-uncovers-a-new-strategy-to-turn-cold-liver-tumour-hot-leading-to-an-effective-and-durable-combined-immunotherapy
https://www.med.cuhk.edu.hk/press-releases/cuhk-uncovers-a-new-strategy-to-turn-cold-liver-tumour-hot-leading-to-an-effective-and-durable-combined-immunotherapy

CUHK Uncovers a New Strategy to Turn “Cold” Liver Tumour “Hot” Leading to an Effective and Durable Combined Immunotherapy

Immunotherapy is a major pillar of cancer therapy. Immune checkpoint inhibitors activate the cancer-killing T cells that had been suppressed by the cancer cells, leading to tumour shrinkage and improved survival rates. However, most of the liver cancers (hepatocellular carcinoma or HCC) are “cold” or T cell-excluded.

 

A new study conducted by the research team of the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) has uncovered that a cancer-promoting gene called histone deacetylase 8 (HDAC8) is responsible for maintaining tumours that are immune cell-excluded. Inhibiting HDAC8 can lead to epigenetic reprogramming of the tumour cell and so increase the infiltration of T cells in the tumour (or turn the tumour “hot”). Further study conducted by the team showed that a new combined immunotherapy using HDAC8 and immune checkpoint inhibitor could protect the mice model, remaining tumour-free in HCC for at least 15 months with no evidence of side effects. The findings have been published in the journal Science Translational Medicine.

 

Prof. Alfred Cheng (left) and Prof. Ka Fai TO

A study conducted by Professor Alfred CHENG (left), Professor from the School of Biomedical Sciences, and Professor Ka Fai TO, Chairman of the Department of Anatomical and Cellular Pathology, at CU Medicine, has uncovered a cancer-promoting gene called HDAC8 is responsible for maintaining tumours that are immune cell-excluded.

The findings provide insights into how the cancer cells are protected and how cancer-killing T cells break through the barricade into the tumour site

 

Previous clinical studies have shown that only 10% to 20% of HCC patients respond to immunotherapy. The major challenge is that most of the HCC tumours are “cold” or T cell-excluded. In other words, even though the soldiers, the T cells, are armed, they are not in proximity to fight against the enemies’ tumour cells.

 

To understanding how the HCC cells are protected from the attack of T cells, researchers from CU Medicine conducted a series of studies using pre-clinical models. HDAC8 was found to be a key factor in maintaining T cell-excluded tumours. A selective HDAC8 inhibitor could cause HCC cells to produce T cell-recruiting molecules. Treatment of HCC-bearing mice with a selective HDAC8 inhibitor resulted in an increased infiltration of T cells into the tumour.  

 

“It is important to identify the role of HDAC8 as we can then identify ways of turning the ‘cold’ T cell-excluded HCC tumours into ‘hot’ tumours, rendering the cancer-killing T cells able to ‘break through’ the barricade into the tumour site. This shows that the HDAC8 inhibitor potentiates the efficacy of immunotherapy in HCC,” said Professor Alfred Sze Lok CHENG, Professor from the School of Biomedical Sciences at CU Medicine.

 

The new treatment brings at least a 15-month tumour-free period 

 

Using a new combined immunotherapy which included an HDAC8 inhibitor and an immune checkpoint inhibitor, researchers found that the mice that received this treatment for 3 weeks were protected against the rechallenge of a subsequent tumour, remaining tumour-free for at least 15 months. Most importantly, there was no evidence of side effects associated with this effective and durable anti-tumour response.       

 

Professor Ka Fai TO, Chairman, Department of Anatomical and Cellular Pathology at CU Medicine, stated, “Our research provides a new and promising approach to treat HCC patients. More than a half of HCC patients have high expressions of HDAC8 protein, thus representing a real-life target in a clinical setting. Based on our findings, we now hope to advance immunotherapy so as to provide greater benefits to HCC patients.”

 

The new treatment is also well tolerated as the selective HDAC8 inhibitor exhibits insignificant toxicity when compared to non-selective HDAC inhibitors. Professor Cheng considers that the new findings are of great value for future clinical development of HDAC8 inhibitors in HCC. As other T cell-excluded cancers such as ovarian and pancreatic tumours also exhibit over-expression of HDAC8, future studies are warranted to elucidate the effects of an HDAC8 inhibitor, and to turn these “cold” tumours “hot” for a more effective immunotherapy.

More Press Releases

CUHK Uncovers Novel Immune Escape Mechanism of Cancer Opening Up New Direction for Cancer Immunotherapy

CUHK Uncovers Novel Immune Escape Mechanism of Cancer Opening Up New Direction for Cancer Immunotherapy

Research
CUHK discovers a blood regulator linked to tumour microenvironment formation,  sparking a new therapeutic target for lung cancer

CUHK discovers a blood regulator linked to tumour microenvironment formation, sparking a new therapeutic target for lung cancer

Research
CU Medicine uncovers the keys for liver cancer adaptation to immunotherapy Pioneering new combination therapy in a Phase II clinical trial

CU Medicine uncovers the keys for liver cancer adaptation to immunotherapy Pioneering new combination therapy in a Phase II clinical trial

Research
 CU Medicine uncovers the key for immune suppression in lung cancer Translating blood’s hidden gem “Neutrophil” into a new generation anti-cancer therapy

CU Medicine uncovers the key for immune suppression in lung cancer Translating blood’s hidden gem “Neutrophil” into a new generation anti-cancer therapy

Research
CUHK unlocks the secret of cancer pain  Identifying a new therapeutic key to ending the sorrow

CUHK unlocks the secret of cancer pain Identifying a new therapeutic key to ending the sorrow

Research
CUHK dissects lung carcinoma at single-cell resolution uncovering a new mechanism for tumour formation

CUHK dissects lung carcinoma at single-cell resolution uncovering a new mechanism for tumour formation

Research
CUHK Uncovers How Immune Cells Turn Bad A New Hope for Kidney Patients

CUHK Uncovers How Immune Cells Turn Bad A New Hope for Kidney Patients

Research
CUHK Unravels the Whole Genome of Nasopharyngeal Cancer A Great Leap Forward in Personalized Medicine Development

CUHK Unravels the Whole Genome of Nasopharyngeal Cancer A Great Leap Forward in Personalized Medicine Development

Research
Why is Liver Cancer More Prevalent in Men than in Women? CUHK Discovers a Sex Hormone-controlled Gene that Promotes Liver Cancer

Why is Liver Cancer More Prevalent in Men than in Women? CUHK Discovers a Sex Hormone-controlled Gene that Promotes Liver Cancer

Research
CU Medicine developed an innovative mRNA drug for treatment of nasopharyngeal carcinoma

CU Medicine developed an innovative mRNA drug for treatment of nasopharyngeal carcinoma

Research
CUHK develops a 3D-printable bioactive material and other technologies to treat large-to-massive tendon injuries

CUHK develops a 3D-printable bioactive material and other technologies to treat large-to-massive tendon injuries

Research
Can animals count?  Neuroscientists at CityUHK and CUHK resolve long-standing debate

Can animals count? Neuroscientists at CityUHK and CUHK resolve long-standing debate

Research
CU Medicine combats resistance to immunotherapy in liver cancer

CU Medicine combats resistance to immunotherapy in liver cancer

Research
CUHK develops novel molecular classification of cancer-associated fibroblasts across multiple cancers, improving understanding for more targeted treatment

CUHK develops novel molecular classification of cancer-associated fibroblasts across multiple cancers, improving understanding for more targeted treatment

Research
A CU Medicine-Baylor College of Medicine collaborative study reveals for the first time that variations in DHX9 underlie human neurodevelopmental disorders

A CU Medicine-Baylor College of Medicine collaborative study reveals for the first time that variations in DHX9 underlie human neurodevelopmental disorders

Research
CU Medicine establishes an internationally accredited biobank:  A prerequisite for Hong Kong to be the hub for new drug development in the Greater Bay Area

CU Medicine establishes an internationally accredited biobank: A prerequisite for Hong Kong to be the hub for new drug development in the Greater Bay Area

Milestone
CUHK unravels the world’s most comprehensive genome profile of the American cockroach and reveals novel cockroach allergens for the development of precision immunotherapy

CUHK unravels the world’s most comprehensive genome profile of the American cockroach and reveals novel cockroach allergens for the development of precision immunotherapy

Research
CUHK discovers a neural architecture that facilitates the formation of associative memory, providing the basis for a deeper understanding of memory and its impairment in brain disorders

CUHK discovers a neural architecture that facilitates the formation of associative memory, providing the basis for a deeper understanding of memory and its impairment in brain disorders

Research
CUHK unveils the evolutionary history of medically important mites, laying the genomics groundwork for diagnosis of and intervention in mite allergy

CUHK unveils the evolutionary history of medically important mites, laying the genomics groundwork for diagnosis of and intervention in mite allergy

Research
Study by CUHK medical students identifies STK3 kinase as a driver in gastric cancer

Study by CUHK medical students identifies STK3 kinase as a driver in gastric cancer

Education
CUHK-HKU-UCL study unravels how gene mutation leads to congenital megacolon providing clues for the development of novel therapeutic strategies

CUHK-HKU-UCL study unravels how gene mutation leads to congenital megacolon providing clues for the development of novel therapeutic strategies

Research
A Joint Study by CUHK, PolyU and Western Sydney University Discovers how the Nervous System of Human Runners Generates More Energetically Efficient Running Forms

A Joint Study by CUHK, PolyU and Western Sydney University Discovers how the Nervous System of Human Runners Generates More Energetically Efficient Running Forms

Research
Insights into B-cells and GPR18 Gene Expression by CU Medicine team  Improve Prediction of Survival in Multiple Cancer Types

Insights into B-cells and GPR18 Gene Expression by CU Medicine team Improve Prediction of Survival in Multiple Cancer Types

Research
CUHK Researchers Uncover Diabetes as a Potential Risk Factor for COVID-19,  and Possible Mechanisms

CUHK Researchers Uncover Diabetes as a Potential Risk Factor for COVID-19, and Possible Mechanisms

Research
CUHK Study Discovers Brain Circuitry That Generates Behavioural Responses to Stress Provide a Basis for Probing Abnormal Repetitive Behaviour Exhibited in Brain Disorders

CUHK Study Discovers Brain Circuitry That Generates Behavioural Responses to Stress Provide a Basis for Probing Abnormal Repetitive Behaviour Exhibited in Brain Disorders

Research
CU Medicine Team Discovers a Novel Prognostic Biomarker for a Doubled Survival in Head and Neck Cancer

CU Medicine Team Discovers a Novel Prognostic Biomarker for a Doubled Survival in Head and Neck Cancer

Research
CUHK to Commence the Next-Generation Clinical Trials of CAR-T Cell Therapy for Haematological Malignancy

CUHK to Commence the Next-Generation Clinical Trials of CAR-T Cell Therapy for Haematological Malignancy

Research
CUHK Study Discovers Pathway That Links to Cognitive Flexibility Dopamine Dysregulation May Lead to Ability Impairment

CUHK Study Discovers Pathway That Links to Cognitive Flexibility Dopamine Dysregulation May Lead to Ability Impairment

Research
CUHK Discovers an Essential Oncogene in Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma

CUHK Discovers an Essential Oncogene in Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma

Research
CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

Research
CUHK Study Discovers an Essential Enzyme to Maintain Body Iron Homeostasis Deficiency Could Cause Excessive Iron Retention and Damage Major Organs

CUHK Study Discovers an Essential Enzyme to Maintain Body Iron Homeostasis Deficiency Could Cause Excessive Iron Retention and Damage Major Organs

Research
CUHK School of Biomedical Sciences Strives to Become the World-leading Biomedical Hub

CUHK School of Biomedical Sciences Strives to Become the World-leading Biomedical Hub

Milestone
CUHK-HKU Study on Multi-gene Mutation-Drug Matching for Recurrent Ovarian Cancer Patients Providing Free Pharmacogenomic Analysis for 100 Patients in Hong Kong

CUHK-HKU Study on Multi-gene Mutation-Drug Matching for Recurrent Ovarian Cancer Patients Providing Free Pharmacogenomic Analysis for 100 Patients in Hong Kong

Research
CUHK Study Reveals Patients with Recovery of Hepatitis B Still at Risk of Liver Cancer

CUHK Study Reveals Patients with Recovery of Hepatitis B Still at Risk of Liver Cancer

Research
CUHK’s Gerald Choa Neuroscience Centre Unveils Mystery of How Brain Learns Motor Skills

CUHK’s Gerald Choa Neuroscience Centre Unveils Mystery of How Brain Learns Motor Skills

Research
CUHK-led Study Reveals Novel Mechanism for the Development of Atherosclerosis Setting New Treatment Directions to Cardiovascular Diseases

CUHK-led Study Reveals Novel Mechanism for the Development of Atherosclerosis Setting New Treatment Directions to Cardiovascular Diseases

Research
CUHK Launches World’s First Study on Ovum Ageing and Female Infertility by Using Single-Cell Genomics Technology

CUHK Launches World’s First Study on Ovum Ageing and Female Infertility by Using Single-Cell Genomics Technology

Research
CUHK/International Study Implicates a Gene in Alzheimer’s disease

CUHK/International Study Implicates a Gene in Alzheimer’s disease

Research
CUHK Unveils Genome of Dermatophagoides farinae Casting New Light on Diagnosis and Interventions of Inhalant Allergies

CUHK Unveils Genome of Dermatophagoides farinae Casting New Light on Diagnosis and Interventions of Inhalant Allergies

Research
CUHK Reveals Effectiveness of TEA for Treating Liver Cancer with a 70% Chance of Completely Destroying Tumor

CUHK Reveals Effectiveness of TEA for Treating Liver Cancer with a 70% Chance of Completely Destroying Tumor

Research
CUHK-HCC Score Accurately Predicts Risk of Liver Cancer in Chronic Hepatitis B Patients Receiving Antiviral Therapy

CUHK-HCC Score Accurately Predicts Risk of Liver Cancer in Chronic Hepatitis B Patients Receiving Antiviral Therapy

Research
CUHK and US Experts Collaborate to Provide Clinical Genetic Training to Set up The Territory's First One-Stop Outpatient Genetic Clinic

CUHK and US Experts Collaborate to Provide Clinical Genetic Training to Set up The Territory's First One-Stop Outpatient Genetic Clinic

International collaboration
CUHK Lo Kwee-Seong Integrated Biomedical Sciences Building Opened

CUHK Lo Kwee-Seong Integrated Biomedical Sciences Building Opened

Milestone
Antiviral Therapy Can Prevent Liver Cancer Recurrence CUHK Represents HK to Draw Up Asian Pacific Treatment Guideline for Chronic Hepatitis B

Antiviral Therapy Can Prevent Liver Cancer Recurrence CUHK Represents HK to Draw Up Asian Pacific Treatment Guideline for Chronic Hepatitis B

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.